QVR’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,500
Closed -$2.32M 73
2026
Q1
$2.32M Buy
9,500
+6,600
+228% +$1.54M 0.09% 35
2025
Q4
$600K Sell
2,900
-5,700
-66% -$1.13M 0.03% 58
2025
Q3
$1.59M Buy
+8,600
New +$1.47M 0.19% 26
2023
Q1
Sell
-5,000
Closed -$883K 88
2022
Q4
$883K Sell
5,000
-36,900
-88% -$6.37M 0.1% 21
2022
Q3
$6.84M Buy
41,900
+20,500
+96% +$3.47M 0.56% 19
2022
Q2
$3.8M Sell
21,400
-81,800
-79% -$14.6M 0.28% 46
2022
Q1
$18.3M Buy
+103,200
New +$17.6M 0.7% 19
2021
Q4
Sell
-45,700
Closed -$7.38M 158
2021
Q3
$7.38M Buy
45,700
+24,300
+114% +$4.15M 0.48% 22
2021
Q2
$3.52M Buy
21,400
+18,700
+693% +$3.1M 0.36% 21
2021
Q1
$444K Sell
2,700
-200
-7% -$32.4K 0.04% 59
2020
Q4
$456K Buy
+2,900
New +$428K 0.04% 22

Other funds holding JNJ

QVR's JNJ Position: Q2 2026 in Review

QVR sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 13,776 shares — an estimated $3.37M sold.

QVR first reported a position in JNJ in Q2 2021 and held it in 7 quarters. The position peaked at $3.37M in Q1 2026. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • QVR reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • QVR sold 13,776 Johnson & Johnson shares in Q2 2026, an estimated $3.37M.
  • QVR first reported a position in Johnson & Johnson in Q2 2021 and held it in 7 quarters.
  • QVR's Johnson & Johnson position peaked at $3.37M in Q1 2026.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.